Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Prudence A. Francis, Olivia Pagani, Gini F. Fleming, et al.
New England Journal of Medicine (2018) Vol. 379, Iss. 2, pp. 122-137
Open Access | Times Cited: 555

Showing 1-25 of 555 citing articles:

Breast Cancer Treatment
Adrienne G. Waks, Eric P. Winer
JAMA (2019) Vol. 321, Iss. 3, pp. 288-288
Closed Access | Times Cited: 3647
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Stefan Aebi, T. Davidson, Günther Gruber, et al.
Annals of Oncology (2010) Vol. 21, pp. v9-v14
Open Access | Times Cited: 2803
Breast cancer
Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2235
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fátima Cardoso, S. Kyriakides, Shinji Ohno, et al.
Annals of Oncology (2019) Vol. 30, Iss. 8, pp. 1194-1220
Open Access | Times Cited: 1717
Breast cancer
Sibylle Loibl, Philip Poortmans, Monica Morrow, et al.
The Lancet (2021) Vol. 397, Iss. 10286, pp. 1750-1769
Closed Access | Times Cited: 1122
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Larissa A. Korde, Mark R. Somerfield, Lisa A. Carey, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 13, pp. 1485-1505
Open Access | Times Cited: 674
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
Harold J. Burstein, Giuseppe Curigliano, Beat Thürlimann, et al.
Annals of Oncology (2021) Vol. 32, Iss. 10, pp. 1216-1235
Open Access | Times Cited: 603
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
Harold J. Burstein, Giuseppe Curigliano, Sibylle Loibl, et al.
Annals of Oncology (2019) Vol. 30, Iss. 10, pp. 1541-1557
Open Access | Times Cited: 584
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 25, pp. 2395-2405
Open Access | Times Cited: 442
Deciphering breast cancer: from biology to the clinic
Emma Nolan, Geoffrey J. Lindeman, Jane E. Visvader
Cell (2023) Vol. 186, Iss. 8, pp. 1708-1728
Open Access | Times Cited: 326
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Nadia Harbeck, Priya Rastogi, Miguel Martín, et al.
Annals of Oncology (2021) Vol. 32, Iss. 12, pp. 1571-1581
Open Access | Times Cited: 308
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
Martine Piccart, Marion Procter, Debora Fumagalli, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 13, pp. 1448-1457
Open Access | Times Cited: 290
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
Martine Piccart, Laura van ‘t Veer, Coralie Poncet, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 4, pp. 476-488
Open Access | Times Cited: 282
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021
William J. Gradishar, Meena S. Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 5, pp. 484-493
Open Access | Times Cited: 265
Progress in adjuvant systemic therapy for breast cancer
Noam Pondé, Dimitrios Zardavas, Martine Piccart
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 1, pp. 27-44
Closed Access | Times Cited: 243
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L. Mayer, Amylou C. Dueck, Miguel Martín, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 2, pp. 212-222
Closed Access | Times Cited: 222
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
Shani Paluch‐Shimon, Fátima Cardoso, Ann H. Partridge, et al.
Annals of Oncology (2020) Vol. 31, Iss. 6, pp. 674-696
Open Access | Times Cited: 221
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
Harold J. Burstein
New England Journal of Medicine (2020) Vol. 383, Iss. 26, pp. 2557-2570
Closed Access | Times Cited: 221
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
Maria Alice Franzoi, Elisa Agostinetto, Marta Perachino, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 7, pp. e303-e313
Open Access | Times Cited: 200
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
Amanda Kerr, David Dodwell, Paul McGale, et al.
Cancer Treatment Reviews (2022) Vol. 105, pp. 102375-102375
Open Access | Times Cited: 196
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Rosie Bradley, Jeremy Braybrooke, Richard Gray, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 3, pp. 382-392
Open Access | Times Cited: 190
Overview of breast cancer
Elyse Watkins
JAAPA (2019) Vol. 32, Iss. 10, pp. 13-17
Open Access | Times Cited: 179
Diagnosis and Treatment of Breast Cancer in Young Women
Lorenzo Rossi, Calogero Mazzara, Olivia Pagani
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 12
Closed Access | Times Cited: 147
The Role of Progesterone Receptors in Breast Cancer
Zhuo Li, Hongrui Wei, Siyan Li, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 305-314
Open Access | Times Cited: 125
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 18, pp. 1645-1656
Open Access | Times Cited: 123
Page 1 - Next Page

Scroll to top